✨ 2 results found - Searched 21962 records in 3ms.
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_proporsi-gambaran-penyakit-paru-interstisial-pada-pasien-kanker-paru-k-20230801083737.jpg&width=120)
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2FCover.jpg.jpg&width=120)
Tesis
Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo- Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
- Nomor Panggil T 15 543 FK